HA
MEDP icon

Homestead Advisers’s Medpace MEDP Stock Holding History

Homestead Advisers’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.73M Buy
7,050
+1,300
+23% +$600K 0.09% 75
2026
Q1 		$2.76M Hold
5,750
– – 0.07% 85
2025
Q4 		$3.23M Hold
5,750
– – 0.09% 80
2025
Q3 		$2.96M Hold
5,750
– – 0.07% 83
2025
Q2 		$1.8M Hold
5,750
– – 0.04% 96
2025
Q1 		$1.75M Sell
5,750
-6,500
-53% -$2.19M 0.04% 90
2024
Q4 		$4.07M Sell
12,250
-8,200
-40% -$2.78M 0.1% 79
2024
Q3 		$6.83M Sell
20,450
-1,500
-7% -$570K 0.16% 57
2024
Q2 		$9.04M Sell
21,950
-2,000
-8% -$792K 0.22% 50
2024
Q1 		$9.68M Sell
23,950
-700
-3% -$246K 0.23% 52
2023
Q4 		$7.56M Hold
24,650
– – 0.19% 57
2023
Q3 		$5.97M Hold
24,650
– – 0.17% 59
2023
Q2 		$5.92M Hold
24,650
– – 0.16% 60
2023
Q1 		$4.64M Sell
24,650
-12,500
-34% -$2.59M 0.13% 70
2022
Q4 		$7.89M Sell
37,150
-9,800
-21% -$1.96M 0.21% 52
2022
Q3 		$7.38M Hold
46,950
– – 0.22% 50
2022
Q2 		$7.03M Hold
46,950
– – 0.2% 55
2022
Q1 		$7.68M Hold
46,950
– – 0.19% 58
2021
Q4 		$10.2M Sell
46,950
-10,800
-19% -$2.26M 0.24% 54
2021
Q3 		$10.9M Sell
57,750
-3,200
-5% -$584K 0.27% 50
2021
Q2 		$10.8M Sell
60,950
-9,000
-13% -$1.55M 0.25% 54
2021
Q1 		$11.5M Hold
69,950
– – 0.27% 50
2020
Q4 		$9.74M Sell
69,950
-1,200
-2% -$151K 0.24% 52
2020
Q3 		$7.95M Hold
71,150
– – 0.22% 56
2020
Q2 		$6.62M Sell
71,150
-700
-1% -$59.6K 0.17% 60
2020
Q1 		$5.27M Sell
71,850
-1,629
-2% -$141K 0.16% 63
2019
Q4 		$6.18M Sell
73,479
-62,761
-46% -$4.86M 0.13% 70
2019
Q3 		$11.4M Buy
136,240
+29,280
+27% +$2.21M 0.23% 77
2019
Q2 		$7M Buy
+106,960
New +$6.16M 0.13% 96

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Homestead Advisers's MEDP Position: Q2 2026 in Review

Homestead Advisers increased its Medpace (MEDP) stake by 23% in Q2 2026, buying an estimated $600K and bringing the position to 7,050 shares worth $3.73M. The position accounts for 0.09% of the portfolio, ranked #75.

Homestead Advisers first reported a position in MEDP in Q2 2019 and has held it in 29 quarters since. The position peaked at $11.5M in Q1 2021. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Homestead Advisers held 7,050 shares of Medpace worth $3.73M as of Q2 2026.
  • Homestead Advisers bought 1,300 Medpace shares in Q2 2026, an estimated $600K.
  • Medpace made up 0.09% of Homestead Advisers's portfolio in Q2 2026, its #75 holding.
  • Homestead Advisers first reported a position in Medpace in Q2 2019 and has held it in 29 quarters since.
  • Homestead Advisers's Medpace position peaked at $11.5M in Q1 2021.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Homestead Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.